HYUNDAI BIOSCIENCE Co., Ltd.
Industry Group: Consumer Durables
Country/Region: South Korea
Identifier: KRX:048410
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Consumer Durables 231 out of 232
Universe
Global Universe 12991 out of 16006
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Taiwan Sakura Corp. |
23.9
Medium
|
189 out of 232 |
Zhejiang Meida Industrial Co., Ltd. |
24.8
Medium
|
197 out of 232 |
XGimi Technology Co., Ltd. |
25.9
Medium
|
202 out of 232 |
HYUNDAI BIOSCIENCE Co., Ltd. |
33.4
High
|
231 out of 232 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
HYUNDAI BIOSCIENCE Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
HYUNDAI BIOSCIENCE Co., Ltd.'s Management of ESG Material Risk is Weak